Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jerome H. Check & Diane L. Check. (2023) The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years. Expert Review of Endocrinology & Metabolism 18:1, pages 5-18.
Read now
Read now
Y. Wang, H. Tahiri, C. Yang, M. Gu, X. Ruan & P. Hardy. (2023) Overexpression of miR-181a regulates the Warburg effect in triple-negative breast cancer. Climacteric 26:1, pages 64-71.
Read now
Read now
Guiju Cai, Xiangyan Ruan, Muqing Gu, Yue Zhao, Yuejiao Wang & Alfred O. Mueck. (2020) PGRMC1 in animal breast cancer tissue and blood is associated with increased tumor growth with norethisterone in contrast to progesterone and dydrogesterone: four-arm randomized placebo-controlled xenograft study. Gynecological Endocrinology 36:11, pages 1024-1027.
Read now
Read now
X. Li, X. Ruan, M. Gu & A. O. Mueck. (2019) PGRMC1 can trigger estrogen-dependent proliferation of breast cancer cells: estradiol vs. equilin vs. ethinylestradiol. Climacteric 22:5, pages 483-488.
Read now
Read now
Articles from other publishers (16)
Sang R. Lee, Young Ho Lee, Seong Lae Jo, Jun H. Heo, Globinna Kim, Geun-Shik Lee, Beum-Soo An, In-Jeoung Baek & Eui-Ju Hong. (2021) Absence of progesterone receptor membrane component 1 reduces migration and metastasis of breast cancer. Cell Communication and Signaling 19:1.
Crossref
Crossref
Zhi Xia, Jian Xiao & Qiong Chen. (2021) Solving the Puzzle: What Is the Role of Progestogens in Neovascularization?. Biomolecules 11:11, pages 1686.
Crossref
Crossref
Yingxue Bai, Marina Ludescher, Gereon Poschmann, Kai Stühler, Martine Wyrich, Julia Oles, André Franken, Mahdi Rivandi, Anna Abramova, Florian Reinhardt, Eugen Ruckhäberle, Dieter Niederacher, Tanja Fehm, Michael A. Cahill, Nadia Stamm & Hans Neubauer. (2021) PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling. Cancers 13:22, pages 5635.
Crossref
Crossref
Sang R. Lee, Hyun Yang, Seong Lae Jo, Young Ho Lee, Hye Won Lee, Bae-keun Park & Eui-Ju Hong. (2021) Suppressed estrogen supply <i>via</i> extra-ovarian progesterone receptor membrane component 1 in menopause. The Journal of Biomedical Research 35:3, pages 228.
Crossref
Crossref
Hannah Asperger, Nadia Stamm, Berthold Gierke, Michael Pawlak, Ute Hofmann, Ulrich M. Zanger, Annamaria Marton, Robert L. Katona, Andrea Buhala, Csaba Vizler, Jan-Philipp Cieslik, Eugen Ruckhäberle, Dieter Niederacher, Tanja Fehm, Hans Neubauer & Marina Ludescher. (2020) Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression. Breast Cancer Research 22:1.
Crossref
Crossref
Laura Terzaghi, Barbara Banco, Debora Groppetti, Priscila C. Dall'Acqua, Chiara Giudice, Alessandro Pecile, Valeria Grieco, Valentina Lodde & Alberto M. Luciano. (2020) Progesterone receptor membrane component 1 (PGRMC1) expression in canine mammary tumors: A preliminary study. Research in Veterinary Science 132, pages 101-107.
Crossref
Crossref
Guiju Cai, Xue Yang, Xiangyan Ruan, Jing Wang, Yi Fang, Yun Wei, Ying Zhang, Muqing Gu & Alfred O. Mueck. (2020) Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with PGRMC1 expression in breast tumour tissue and with clinical breast tumour characteristics. Maturitas 140, pages 64-71.
Crossref
Crossref
Xiaoxiao Lu, Anqi Guan, Xi Chen, Jian Xiao, Mingxuan Xie, Baishuang Yang, Shuya He, Shaojin You, Wei Li & Qiong Chen. (2019) mPRα mediates P4/Org OD02‐0 to improve the sensitivity of lung adenocarcinoma to EGFR‐TKIs via the EGFR‐SRC‐ERK1/2 pathway. Molecular Carcinogenesis 59:2, pages 179-192.
Crossref
Crossref
Yue Zhao & Xiangyan Ruan. (2020) Identification of PGRMC1 as a Candidate Oncogene for Head and Neck Cancers and Its Involvement in Metabolic Activities. Frontiers in Bioengineering and Biotechnology 7.
Crossref
Crossref
Nishel M. Shah, Pei F. Lai, Nesrina Imami & Mark R. Johnson. (2019) Progesterone-Related Immune Modulation of Pregnancy and Labor. Frontiers in Endocrinology 10.
Crossref
Crossref
Xiangyan Ruan & Alfred O. Mueck. (2019) The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue. Hormone Molecular Biology and Clinical Investigation 37:1.
Crossref
Crossref
Marina Willibald, Giuliano Bayer, Vanessa Stahlhut, Gereon Poschmann, Kai Stühler, Berthold Gierke, Michael Pawlak, Harald Seeger, Alfred O. Mueck, Dieter Niederacher, Tanja Fehm & Hans Neubauer. (2017) Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells. Oncotarget 8:42, pages 72480-72493.
Crossref
Crossref
Yue Zhao, Xiangyan Ruan, Husheng Wang, Xue Li, Muqing Gu, Lijuan Wang, Yanglu Li, Harald Seeger & Alfred O. Mueck. (2017) The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model. Maturitas 102, pages 26-33.
Crossref
Crossref
Xiangyan Ruan, Ying Zhang, Alfred O. Mueck, Marina WillibaldHarald Seeger, Tanja FehmSara Brucker & Hans Neubauer. (2017) Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer. Menopause 24:2, pages 203-209.
Crossref
Crossref
Alfred O. Mueck. (2017) Transdermales Östradiol und ProgesteronTransdermal estradiol and progesterone. Gynäkologische Endokrinologie 15:1, pages 65-72.
Crossref
Crossref
Michael A. Cahill, Jalal A. Jazayeri, Susan M. Catalano, Shinya Toyokuni, Zaklina Kovacevic & Des R. Richardson. (2016) The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1866:2, pages 339-349.
Crossref
Crossref